Condyloma Acuminatum Pathology: Key Insights For Diagnosis

Detailed histopathological analysis of condyloma acuminatum, genital warts caused by HPV types 6 and 11.

By Medha deb

Created on Jan 29, 2026

Detailed histopathological analysis of condyloma acuminatum, genital warts caused by HPV types 6 and 11.

Condyloma acuminatum, commonly known as genital warts, represents a benign epithelial proliferation induced by low-risk human papillomavirus (HPV) types, primarily 6 and 11. This condition manifests as exophytic lesions on anogenital mucosa and skin, characterized histologically by papillomatosis, koilocytosis, and squamous hyperplasia.

Clinical features

Condyloma acuminatum presents as soft, flesh-coloured papules or plaques with a verrucous, cauliflower-like surface. Lesions typically measure a few millimetres but can coalesce into larger aggregates spanning several centimetres. Common sites include the penile shaft, glans, vulva, perineum, perianal region, and less frequently, oral mucosa. Appearance varies from filiform projections to sessile plaques. Symptoms are often absent, though pruritus, irritation, or bleeding may occur with friction or trauma. In pregnancy, lesions may enlarge significantly, potentially obstructing delivery.

Flesh-coloured or hyperpigmented papules/plaques
Verrucous or cauliflower-like surface
Moist mucosal surfaces (e.g., coronal sulcus, fourchette)
Dry keratinized skin (e.g., penile shaft)
Linear configuration along scratches (Koebner phenomenon)

Immunocompromised individuals, including those with HIV, exhibit more extensive, refractory lesions with higher recurrence rates.

Pathology

Microscopic examination reveals characteristic features confirming HPV-induced changes. The hallmark is acanthotic squamous epithelium arranged in papillary or verrucous architecture with elongated rete ridges forming finger-like projections.

Low power

At scanning magnification, condyloma acuminatum displays exophytic growth with marked papillomatosis. Dermal papillae are elongated and thickened, covered by hyperplastic stratified squamous epithelium. The silhouette resembles a church spire or cauliflower floret. Parakeratosis and hyperkeratosis are prominent on the surface.

High power

Epithelial cells exhibit koilocytosis: perinuclear halos surrounding hyperchromatic, irregular nuclei, often with binucleation. These HPV-infected cells have abundant eosinophilic cytoplasm and raisinoid nuclei. Mitotic figures may appear in the lower epithelium, but dysplasia is absent in pure condyloma.

Papillomatosis: Upward elongation of dermal papillae
Acanthosis: Thickened spinous layer
Koilocytosis: Perinuclear clearing, nuclear atypia
Parakeratosis/hyperkeratosis: Retained nuclei in stratum corneum
Angiomatoid stroma: Dilated capillaries in papillae

Immunohistochemistry shows diffuse p16 negativity (distinguishing from high-risk HPV lesions) and positive HPV in situ hybridization for types 6/11.

Histopathology images

Scanning view demonstrates papillary architecture with koilocyte-filled epithelium (Figure 1). High-power image highlights perinuclear halos and binucleate cells (Figure 2). These features are diagnostic.

Differential diagnosis

Accurate differentiation relies on clinical-pathologic correlation. Key mimics include:

Entity	Key Distinguishing Features
Seborrhoeic keratosis	Stuck-on appearance, basaloid cells, pseudohorn cysts; older patients
Squamous cell carcinoma	Full-thickness atypia, invasion, keratin pearls; high-risk HPV+
Bowenoid papulosis	High-risk HPV (16/18), pagetoid spread, p16 diffuse+
Molluscum contagiosum	Henderson-Patterson bodies, intracytoplasmic inclusions
Vulval intraepithelial neoplasia	Surface maturation, high-risk HPV markers

Biopsy is essential for atypical, pigmented, or ulcerated lesions.

Diagnosis

Clinical diagnosis suffices for classic presentations. Confirmatory biopsy is indicated for diagnostic uncertainty, treatment failure, pigmentation, induration, ulceration, or immunocompromise. Colposcopy/aceto-whitening reveals subclinical lesions. HPV typing via PCR distinguishes low- vs high-risk strains.

Treatment

No therapy eradicates latent HPV; treatments target visible lesions. Patient-applied options include podophyllotoxin (0.5% solution/0.15% gel) and imiquimod 5% cream. Provider-administered therapies encompass cryotherapy (liquid nitrogen), trichloroacetic acid 80-90%, surgical excision, electrocautery, and CO2 laser ablation.

Patient-applied: Podophyllotoxin (bid x3d/wk x4wk), Imiquimod (3x/wk x16wk)
Provider-applied: Cryotherapy (q1-2wk), TCA (q1-2wk)
Ablative: Curettage/electrodesiccation, laser, excision

HPV vaccination (Gardasil 9) prevents new infections but not active disease.

Prognosis and complications

Spontaneous regression occurs in one-third of immunocompetent patients within 12 months. Recurrence rates range 20-50% due to viral latency. Rare malignant transformation (<1%) reported in immunocompromised hosts.

Complications include autoinoculation, psychosexual distress, and pregnancy-related enlargement.

Frequently asked questions

What causes condyloma acuminatum?

Low-risk HPV types 6 and 11 via skin-to-skin contact, primarily sexual transmission.

Is condyloma acuminatum cancerous?

No, it is benign. Malignant transformation is exceedingly rare.

Do genital warts resolve spontaneously?

Yes, up to 30% regress without treatment, especially in young patients.

How is HPV transmission prevented?

Consistent condom use, HPV vaccination, partner screening.

Does treatment cure HPV infection?

No, it removes warts but virus persists latently; recurrence common.

Condyloma Acuminatum Pathology: Key Insights For Diagnosis

Clinical features